Ebola outbreak in DR Congo
Analysis based on 6 articles · First reported Aug 27, 2026 · Last updated Aug 28, 2026
The outbreak is straining healthcare systems and humanitarian resources in Central Africa, potentially affecting regional stability and investment. Pharmaceutical and healthcare companies involved in Ebola vaccines or treatments may see increased demand, while travel and trade in affected regions could face disruptions.
The Ebola Bundibugyo outbreak in the Democratic Republic of the Congo (DRC) has spread to six provinces, with more than 5,600 cases and 2,700 deaths since mid-May. The UN Secretary-General called for urgent action and an additional $1.1 billion in funding, warning that current resources will last only weeks. The response is hampered by insecurity, with over 40 healthcare workers killed and attacks on treatment centers. The World Health Organization (WHO) has deployed over 260 experts and delivered 330 tonnes of supplies. Preparedness efforts are underway in neighboring Burundi, while Uganda's outbreak has been declared over after 42 days without a new case. UN agencies, including UNICEF, WFP, and IOM, are supporting the response.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard